KAL1 Antikörper (Internal Region)
Kurzübersicht für KAL1 Antikörper (Internal Region) (ABIN6099526)
Target
Alle KAL1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Internal Region
-
Aufreinigung
- Affinity Chromatography
-
Immunogen
- Synthesized peptide derived from the Internal region of human KALIG-1.
-
Isotyp
- IgG
-
-
anti-Kallmann Syndrome 1 Sequence (KAL1) (AA 200-300) antibody
KAL1 Reaktivität: Human WB, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Kallmann Syndrome 1 Sequence (KAL1) antibodyKAL1 Reaktivität: Human, Maus, Ratte IF Wirt: Kaninchen Polyclonal unconjugated
anti-Kallmann Syndrome 1 Sequence (KAL1) (AA 548-657) antibodyKAL1 Reaktivität: Human WB, ELISA Wirt: Maus Polyclonal unconjugated
anti-Kallmann Syndrome 1 Sequence (KAL1) (AA 548-657) antibodyKAL1 Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 2E8 unconjugated
anti-Kallmann Syndrome 1 Sequence (KAL1) (AA 166-194), (N-Term) antibodyKAL1 Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB39497 unconjugated
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Aliquot and store at -20 °C or -80 °C. Avoid repeated freeze/thaw cycles.
-
-
- KAL1 (Kallmann Syndrome 1 Sequence (KAL1))
-
Andere Bezeichnung
- KAL1
-
Gen-ID
- 3730
-
UniProt
- P23352
Target
-
